Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
NEU:ASX
Neuren Pharmaceuticals Ltd
12,47 A$
+0,08%
(+0,010) 1D
1 may, 16:10:09 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NEU...
Açın
12,60 A$
High
12,80 A$
Low
12,47 A$
Mkt. cap
1,58 mlrd
Avg. vol.
446,68K
Volume
234,98K
P/E ratio
53,58
52-wk high
22,98 A$
52-wk low
11,00 A$
EPS
0,23 A$
Shares outstanding
126,50 mln
No. of employees
8
News stories
From sources across the web
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
14,14 mln
14,14 mln
18,19 mln
18,19 mln
Cost of goods sold
7,45 mln
7,45 mln
10,75 mln
10,75 mln
Cost of revenue
7,45 mln
7,45 mln
10,75 mln
10,75 mln
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,24 mln
1,24 mln
1,87 mln
1,87 mln
Operating expense
1,24 mln
1,24 mln
1,87 mln
1,87 mln
Total operating expenses
8,69 mln
8,69 mln
12,62 mln
12,62 mln
Operating income
5,45 mln
5,45 mln
5,57 mln
5,57 mln
Other non operating income
-1,31 mln
-1,31 mln
-337,50K
-337,50K
EBT including unusual items
9,86 mln
9,86 mln
9,60 mln
9,60 mln
EBT excluding unusual items
9,86 mln
9,86 mln
9,60 mln
9,60 mln
Income tax expense
2,34 mln
2,34 mln
1,90 mln
1,90 mln
Effective tax rate
23,78%
23,78%
19,80%
19,80%
Other operating expenses
-
-
-
-
Net income
7,52 mln
7,52 mln
7,70 mln
7,70 mln
Net profit margin
53,16%
53,16%
42,35%
42,35%
Earnings per share
-
-
-
-
Interest and investment income
3,15 mln
3,15 mln
2,93 mln
2,93 mln
Interest expense
-
-
-
-
Net interest expenses
3,15 mln
3,15 mln
2,93 mln
2,93 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
5,45 mln
5,45 mln
5,58 mln
5,58 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer